z-logo
open-access-imgOpen Access
DFMO Reduces Cortical Infarct Volume after Middle Cerebral Artery Occlusion in the Rat
Author(s) -
Cheryl A. Muszynski,
Claudia S. Robertson,
J. Clay Goodman,
Charles M. Henley
Publication year - 1993
Publication title -
journal of cerebral blood flow and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.167
H-Index - 193
eISSN - 1559-7016
pISSN - 0271-678X
DOI - 10.1038/jcbfm.1993.131
Subject(s) - ornithine decarboxylase , ischemia , polyamine , medicine , middle cerebral artery , stroke (engine) , infarction , striatum , anesthesia , endocrinology , pharmacology , chemistry , enzyme , biochemistry , dopamine , myocardial infarction , mechanical engineering , engineering
Ornithine decarboxylase (ODC), a key enzyme in polyamine biosynthesis, is induced in ischemic tissue and may mediate vasogenic edema and delayed neuronal death. We determined the effects of α-difluoromethylornithine (DFMO), a specific inhibitor of ODC, on infarct size and ODC activity in a rat model of transient focal ischemia. DFMO blocked the ischemia-induced increase in ODC and significantly reduced infarct volumes by 57–45%, depending upon the treatment regimen. These studies suggest that polyamine metabolism plays a role in the development of cerebral infarction after focal ischemia and that DFMO may be useful in limiting injury after a stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom